These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8449205)

  • 41. Ramipril and captopril in patients with heart failure: effects on hemodynamics and vasoconstrictor systems.
    Manthey J; Osterziel KJ; Röhrig N; Dietz R; Hackenthal E; Schmidt-Gayk H; Kübler W
    Am J Cardiol; 1987 Apr; 59(10):171D-175D. PubMed ID: 2953224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Renal effects of captopril in chronic heart failure].
    Zolotov NA; Kiriaev AA; Merzon AK; Mukharliamov NM
    Ter Arkh; 1988; 60(8):46-51. PubMed ID: 3067412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormone.
    Laragh JH
    Drugs; 1986; 32 Suppl 5():1-12. PubMed ID: 2952486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Captopril and hypertensive cardiopathy : therapeutic effects and hormonal changes].
    Palazzuoli V; Mondillo S; Galli M; Kristodhullu S; Faglia S; D'Aprile N; Martorelli T
    Cardiologia; 1990 Jun; 35(6):489-93. PubMed ID: 2150343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives.
    Wilkins MR; Lewis HM; West MJ; Kendall MJ; Lote CJ
    J Hum Hypertens; 1987 Jun; 1(1):47-51. PubMed ID: 2977404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease.
    Dakak N; Makhoul N; Flugelman MY; Merdler A; Shehadeh H; Schneeweiss A; Halon DA; Lewis BS
    Am J Cardiol; 1990 Sep; 66(5):608-13. PubMed ID: 2118301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute and chronic effects of captopril therapy in patients with refractory heart failure.
    Walsh WF; Lee CL
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896
    [No Abstract]   [Full Text] [Related]  

  • 50. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K; Punzengruber C; Sinzinger H
    Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aldosterone and prolactin responsiveness after prolonged treatment of congestive heart failure with captopril.
    Jungmann E; Störger H; Althoff PH; Hadler D; Fassbinder W; Bussmann WD; Kaltenbach M; Schöffling K
    Eur J Clin Pharmacol; 1985; 28(1):1-4. PubMed ID: 3886398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.
    Packer M; Medina N; Yushak M; Lee WH
    Br Heart J; 1985 Sep; 54(3):298-304. PubMed ID: 2994697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.
    Riegger GA; Haeske W; Kraus C; Kromer EP; Kochsiek K
    Am J Cardiol; 1987 Apr; 59(8):906-10. PubMed ID: 3548307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.